These pathways, which are mainly related to extracellular matrix composition, cellular migration and neurodevelopment, include the IGF signaling pathway, whose overexpression was previously shown to improve disease features in SMA preclinical models [67, 68]. This evidence concerns the gene IGF1 and proximal spinal muscular atrophy.